T

TherapeuticsMD, Inc.

TXMD Nasdaq Healthcare · Pharmaceutical Preparations Boca Raton, FL www.therapeuticsmd.com
$2.18
Mkt Cap 25.2M
Throughout this Annual Report on Form 10-K ( 2025 10-K Report ), the terms we, us, our, TherapeuticsMD, the Company, or our company refer to TherapeuticsMD, Inc., a Nevada corporation, and unless spec…

Throughout this Annual Report on Form 10-K ( 2025 10-K Report ), the terms we, us, our, TherapeuticsMD, the Company, or our company refer to TherapeuticsMD, Inc., a Nevada corporation, and unless specified otherwise, include our wholly owned subsidiaries vitaMedMD, LLC, a Delaware limited liability company ( vitaMed ), and BocaGreenMD, Inc., a Nevada corporation ( BocaGreen ). TherapeuticsMD is a pharmaceutical royalty company that owns or has rights to trademarks, service marks, or trade names that were previously used in connection with the operation of its business, or are now licensed by another party, including TherapeuticsMD , vitaMedMD , BocaGreenMD , BIJUVA , and IMVEXXY , which are protected under applicable intellectual property laws and are the property of the Company. This 2025 10-K Report also contains trademarks, trade names and service marks of other companies, which are the property of their respective owners. Solely for convenience, trademarks, trade names and service marks referred to in this 2025 10-K Report may appear without the , or SM symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the right of the applicable licensor to these trademarks, trade names, and service marks. We do not intend our use or display of other parties’ trademarks, trade names or service marks to imply, and such use or display should not be construed to imply a relationship with, or endorsement or sponsorship of us by, these other parties.

/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$3.3M
FCF TTM
-$169.7M
Running full 6-factor analysis…